FDA O O O O
warns O O O O
consumers O O O O
about O O O O
homeopathic O O O O
teething O O O O
products O O O O
The O O O O
FDA O O O O
is O O O O
[warning O O O O
consumers](/news-events/press-announcements/fda-confirms-elevated-levels-belladonna-certain-homeopathic-teething-products) O O O O
that O O O O
homeopathic O O O O
teething O O O O
tablets O O O O
containing O O O O
belladonna O O O O
pose O O O O
an O O O O
unnecessary O O O O
risk O O O O
to O O O O
infants O O O O
and O O O O
children O O O O
and O O O O
urges O O O O
consumers O O O O
not O O O O
to O O O O
use O O O O
these O O O O
products O O O O
and O O O O
dispose O O O O
of O O O O
any O O O O
in O O O O
their O O O O
possession. O O O O
FDA Reason 1 O O
has Reason 1 O O
completed Reason 1 O O
testing Reason 1 O O
of Reason 1 O O
homeopathic Reason 1 O O
teething Reason 1 O O
tablets Reason 1 O O
labeled Reason 1 O O
as Reason 1 O O
containing Reason 1 O O
belladonna Reason 1 O O
and Reason 1 O O
other Reason 1 O O
ingredients Reason 1 O O
and Reason 1 O O
marketed Reason 1 O O
by Reason 1 O O
CVS Reason 1 O O
and Reason 1 O O
Hyland's Reason 1 O O
Inc. Reason 1 O O
Our O O O O
testing O O O O
found O O O O
that O O O O
the O O O O
belladonna O O O O
alkaloids O O O O
(atropine O O O O
and O O O O
scopolamine) O O O O
content O O O O
and O O O O
coffea O O O O
cruda O O O O
(caffeine) O O O O
content O O O O
is O O O O
not O O O O
uniform O O O O
among O O O O
the O O O O
manufactured O O O O
tablets. O O O O
FDA Reason 2 O O
analysis Reason 2 O O
found Reason 2 O O
the Reason 2 O O
levels Reason 2 O O
of Reason 2 O O
atropine Reason 2 O O
and Reason 2 O O
scopolamine Reason 2 O O
in Reason 2 O O
some Reason 2 O O
of Reason 2 O O
the Reason 2 O O
CVS Reason 2 O O
tablets Reason 2 O O
and Reason 2 O O
the Reason 2 O O
levels Reason 2 O O
of Reason 2 O O
scopolamine Reason 2 O O
in Reason 2 O O
some Reason 2 O O
of Reason 2 O O
the Reason 2 O O
Hyland's Reason 2 O O
tablets Reason 2 O O
far Reason 2 O O
exceeded Reason 2 O O
the Reason 2 O O
amount Reason 2 O O
stated Reason 2 O O
on Reason 2 O O
the Reason 2 O O
products' Reason 2 O O
labels. Reason 2 O O
See O O O O
[Laboratory O O O O
Analysis O O O O
of O O O O
Homeopathic O O O O
Teething O O O O
Tablets](/drugs/information-drug-class/laboratory-analysis-homeopathic-teething-tablets) O O O O
for O O O O
more O O O O
information. O O O O
Additional O O O O
Information O O O O
[FDA O O O O
announces O O O O
Company's O O O O
nationwide O O O O
voluntary O O O O
recall O O O O
of O O O O
Hyland's O O O O
teething O O O O
tablets](/drugs/drug-safety-and-availability/fda-announces-standard-homeopathic-companys-nationwide-voluntary-recall-hylands-teething-tablets)(4/30/2017) O O O O
products](/news-events/press-announcements/fda-confirms-elevated-levels-belladonna-certain-homeopathic-teething-products)(1/27/2017) O O O O
[FDA O O O O
warns O O O O
of O O O O
homeopathic O O O O
gels](/news-events/press-announcements/fda-warns-against-use-homeopathic-teething-tablets-and-gels)(9/30/2016) O O O O
[FDA O O O O
issues O O O O
warning O O O O
letter O O O O
to O O O O
[FDA O O O O
issues O O O O
warning O O O O
letter O O O O
to O O O O
Homeolab O O O O
USA O O O O
letter O O O O
Their O O O O
Gums? O O O O
No](/consumers/consumer-updates/do-teething-babies-need-medicine-their-gums-no) O O O O
Adverse O O O O
Event O O O O
Reporting O O O O
Systems O O O O
(FAERS) O O O O
- O O O O
Teething O O O O
tablet O O O O
AERS O O O O
Part O O O O
1 O O O O
of O O O O
3](/media/123552/download?attachment) O O O O
[FDA O O O O
Adverse O O O O
Event O O O O
Reporting O O O O
Systems O O O O
(FAERS) O O O O
- O O O O
Teething O O O O
tablet O O O O
Part O O O O
2 O O O O
of O O O O
3](/media/123555/download?attachment) O O O O
[FDA O O O O
Adverse O O O O
Event O O O O
Reporting O O O O
Systems O O O O
(FAERS) O O O O
- O O O O
